Granite Bio is a startup based in Switzerland, most recent round Series B, 2 tracked investors.
Granite Bio is a startup founded in 2020 based in Switzerland. Its most recent tracked round is Series B. Brouky records 2 investors associated with the company.
Granite Bio is a clinical-stage biotechnology company developing first-in-class therapeutic antibodies targeting the root causes of inflammatory, autoimmune, and fibrotic diseases by selectively depleting pathogenic cells.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.